Express Pharma (Vol.10, No.21) September 1-15, 2015
India's Foremost Pharma & BioTech Magazine
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
UBM India announces PharmaLytica 2015
The event will be held in Hyderabad at HITEX Exhibition Centre on September 2 and 3, 2015
Novartis with WHO to work together to eliminate leprosy, sign five year agreement
Novartis Foundation's new leprosy contact tracing programme launched in five countries
US FDA approves Repatha to treat certain patients with high cholesterol
The most common side effects of Repatha include nasopharyngitis, upper respiratory tract infection, flu, back pain, and reactions…
India is free of maternal and neonatal tetanus: PM
The country has achieved under-five mortality rate decline at an accelerated pace compared to the global rate of decline and India…
Dr Reddy’s North America head quits
Umang Vohra was previously Dr Reddy's Laboratories's Chief Financial Officer in India
Dr Reddy’s Laboratories North America head…
Lupin receives FDA approval for generic prilosec capsules
It is indicated for the short-term treatment of duodenal ulcer, gastric ulcer and treatment of GERD
Scientists aim to develop drugs to eliminate pancreatic cancer
The research team has carried out some preliminary studies of LXR expression in patient tumour samples and is preparing to analyse…
Aurobindo gets US FDA nod for hepatitis B drug
Entecavir tablets are indicated for treatment of chronic hepatitis B virus infection of the liver
Aurobindo Pharma has received…
PHFI-IHME-led Lancet paper examines fatal and non-fatal health loss across in India
Even as life expectancy increases in India, tuberculosis and neonatal preterm birth complications continue to take a high toll on…